Autoantibodies to double-stranded DNA–intermethod comparison between four commercial immunoassays and a research biosensor-based device
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Patients with systemic lupus erythematosus (SLE) often develop a wide variety of serological manifestations including the presence of antibodies to double-stranded DNA (anti-dsDNA). Positivity for anti-dsDNA constitutes one of the laboratory criteria for the diagnosis of SLE and is therefore clinically relevant. We analyzed the diagnostic accuracies of four commercial anti-dsDNA immunoassays and compared the results with a recently established surface plasmon resonance (SPR) biosensor chip with covalently chip-immobilized dsDNA. The anti-dsDNA measurements were performed retrospectively in 50 patients with clinically proven SLE, 39 patients with other autoimmunopathies and 20 healthy controls. Data were evaluated by Receiver-Operator Characteristic (ROC) analysis, with special regard to SLE patients suffering from lupus nephritis. The ROC analyses for the four immunoassays and the SPR biosensor resulted in the following area-under-the-curve (AUC) and diagnostic efficiency (DE) values in descending order: Bindazyme AUC, 0.89; DE, 0.88; ELiA AUC, 0.89; DE, 0.86; SPR biosensor AUC, 0.82; DE, 0.80; Farrzyme AUC, 0.77; DE, 0.77; Farr AUC, 0.77; DE, 0.70. When considering the 22 nephritis SLE patients the following AUC were observed: Bindazyme 0.98; EliA 0.95; SPR biosensor 0.93; Farr 0.89; Farrzyme 0.88. Although various methodologies for the determination of anti-dsDNA were compared, the overall diagnostic accuracy was found satisfactory in all immunoassays. Best data were found for the Bindazyme assay. We referenced the measurements to our in-house SPR biosensor device which showed good AUC and DE values. When optimized, this technique, allowing to monitor antigen/ antibody interactions in real-time, may add a new analytical quality to the existing methods, potentially beneficial in diagnosis and clinical monitoring of SLE.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consequently, correlation between assays can be poor”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [51]
In the citing paper
“Fiegel et al. compared the AUC of the ROC curves for ELISA (Bindazyme, Farrzyme), FEIA and Farr and found the highest AUC for FEIA and Bindazyme [51].”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [51]
In the citing paper
“Some studies also evaluated correlation between assays and overall, a low correlation was found (r < 0.72) [43], [51], [77].”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [51]
Citations
Cites
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Hanley, J. A., & McNeil, B. J. (1983) · Radiology · doi:10.1148/radiology.148.3.6878708 · Cited by 7,016
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A., & Harley, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021933 · Cited by 2,578
D'Cruz, D. P., Khamashta, M. A., & Hughes, G. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60279-7 · Cited by 992
Kotzin, B. L. (1996) · Cell · doi:10.1016/s0092-8674(00)81108-3 · Cited by 660
Heinlen, L. D., McClain, M. T., Merrill, J., Akbarali, Y. W., Edgerton, C. C., Harley, J. B., & James, J. A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22665 · Cited by 202
Manson, J. J., Ma, A., Rogers, P., Mason, L. J., Berden, J. H., van der Vlag, J., D'Cruz, D. P., Isenberg, D. A., & Rahman, A. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2831 · Cited by 129
Bootsma, H., Spronk, P. E., Borg, E. J. T., Hummel, E. J., de Boer, G., Limburg, P. C., & Kallenberg, C. G. M. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.11.661 · Cited by 115
Research works printed but not linked: 2
- Jönsson U., 1992, Real time biospecific interaction analysis - the integration of surface plasmon resonance detection, general biospecific interface chemistry and microfluidics into one analytical system
- 10.1002/(SICI)1099-1352(199812)11:1/6<163::AID-JMR414>3.0.CO;2-U · DOI · Paper page
Cited by
Critical Issues in Sensor Science To Aid Food and Water Safety
Farahi, R. H., Passian, A., Tétard, L., & Thundat, T. G. (2012) · ACS Nano · doi:10.1021/nn204999j · Cited by 101
Mummert, E., Fritzler, M. J., Sjöwall, C., Bentow, C., & Mahler, M. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.05.014 · Cited by 86
Biosensors for Diagnostic Applications
Gruhl, F. J., Rapp, B. E., & Länge, K. (2011) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2011_130 · Cited by 80
Andrejevic, S., Jeremic, I., Sefik-Bukilica, M., Nikolic, M., Stojimirovic, B., & Bonaci-Nikolic, B. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2330-3 · Cited by 56
“Other authors also suggested that the newest generation ELISA tests may replace CLIFTas a screening assay, and the Farr assay, as a specific test for anti-dsDNA antibody detection [21, 23–26].”
MethodInfantino, M., Meacci, F., Bentow, C., Martis, P., Benucci, M., Afeltra, A., Rigon, A., Atzeni, F., Sarzi-Puttini, P., Manfredi, M., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/902821 · Cited by 41
Metadata
- Authors
- Fiegel, F., Buhl, A., Jaekel, H.-P., Werle, E., Schmolke, M., Ollert, M., & Luppa, P.
- Affiliations
- TUM Klinikum (DE)
- Dietrich Bonhoeffer Klinikum (DE)
- München Klinik (DE)
- Institut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar der Technischen Universität München, München,
- ORCID
- Ollert, M.
- Venue
- Lupus
- Publisher
- SAGE Publications
- Published
- 2010-06-25
- Volume
- 19
- Issue
- 8
- Pages
- 957-964
- ISSN
- 0961-2033 (ISSN-L)
- 1477-0962
- OpenAlex
- W2082971416
- Semantic Scholar
- 154370711945e7c49dd8dc248aba7df0f8540388
- Cited by
- 24
- References
- 22
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2022: 2 · 2019: 1 · 2018: 5 · 2016: 2 · 2015: 1 · 2013: 4 · 2012: 2
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Lupus (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- anti-dsDNA antibodies, systemic lupus erythematosus, lupus nephritis, immunoassay comparison, surface plasmon resonance biosensor, diagnostic accuracy, autoantibodies, ELISA
- MeSH terms
- Antibodies, Antinuclear, Autoantibodies, DNA, Humans, Immunoassay, Lupus Erythematosus, Systemic, ROC Curve, Sensitivity and Specificity, Biosensing Techniques, Surface Plasmon Resonance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autoantibodies to double-stranded DNA–intermethod comparison between four commercial immunoassays and a research biosensor-based device. https://app.cochat.ai/papers/10.1177/0961203310369681
- The paper
- Fiegel, F., Buhl, A., Jaekel, H.-P., Werle, E., Schmolke, M., Ollert, M., & Luppa, P. (2010). Autoantibodies to double-stranded DNA–intermethod comparison between four commercial immunoassays and a research biosensor-based device. Lupus. https://doi.org/10.1177/0961203310369681
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.